Centessa Pharmaceuticals PLC CNTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EST
3.98quote price arrow down-0.07 (-1.73%)
Volume
71,265
52 week range
2.88 - 13.83
Loading...
  • Open4.12
  • Day High4.17
  • Day Low3.90
  • Prev Close4.05
  • 52 Week High13.83
  • 52 Week High Date12/03/21
  • 52 Week Low2.88
  • 52 Week Low Date06/03/22

Key Stats

  • Market Cap376.493M
  • Shares Out94.60M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-64.65

KEY STATS

  • Open4.12
  • Day High4.17
  • Day Low3.90
  • Prev Close4.05
  • 52 Week High13.83
  • 52 Week High Date12/03/21
  • 52 Week Low2.88
  • 52 Week Low Date06/03/22
  • Market Cap376.493M
  • Shares Out94.60M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-64.65

RATIOS/PROFITABILITY

  • EPS (TTM)-2.52
  • P/E (TTM)-1.58
  • Fwd P/E (NTM)-1.97
  • EBITDA (TTM)-218.153M
  • ROE (TTM)-43.77%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)16.05%

EVENTS

  • Earnings Date03/30/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Centessa Pharmaceuticals PLC

 

Profile

MORE
Centessa Pharmaceuticals plc (Centessa) is a pharmaceutical company. The Company's asset-centric programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. Its portfolio consists of approximately 16 conviction programs, including four programs evaluated in clinical trials and 12 additional preclinical programs. Centessa's...
Francesco de Rubertis Ph.D.
Independent Chairman of the Board
Saurabh Saha M.D., Ph.D.
Chief Executive Officer, Director
Gregory Weinhoff M.D.
Chief Financial Officer, Chief Accounting Officer
Thomas Templeman Ph.D.
Chief Technology Officer
Antoine Yver M.D.
Executive Vice President and Chairman of Development
Address
3Rd Floor, 1 Ashley Road
Altrincham
WA14 2DT
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
VIGL
Vigil Neuroscience Inc
12.25+1.26+11.46%
PHAT
Phathom Pharmaceuticals Inc
9.20-0.33-3.46%
BCAB
Bioatla Inc
9.85-0.08-0.81%
KOD
Kodiak Sciences Inc
7.15-0.39-5.17%
RANI
Rani Therapeutics Holdings Inc
8.02+0.02+0.25%